MIST — Milestone Pharmaceuticals Share News
0.000.00%
Last trade - 00:00- $80.70m
- $51.06m
- $1.55m
U.S. STOCKS ON THE MOVE-Boeing, Chemours, C3.ai
Milestone Pharma slides on deep-discounted stock offering
Brief: Milestone Pharmaceuticals Prices $30 Mln Public Offering
Brief: Milestone Pharmaceuticals Announces Proposed Public Offering Of Common Shares And Pre-Funded Warrants
U.S. STOCKS ON THE MOVE-TPG, R1 RCM, Zoom
U.S. STOCKS ON THE MOVE-Micron, Krystal Biotech, Pilgrim's Pride
Milestone Pharma up on plans to resubmit FDA application for heart drug
Brief: Milestone Pharmaceuticals Announces Plan to Resubmit NDA for Etripamil for the Treatment of PSVT
U.S. STOCKS ON THE MOVE-APA, Etsy, Global Gas
U.S. STOCKS ON THE MOVE-Carnival corp, Exxon Mobil, Vince Holding
U.S. STOCKS ON THE MOVE-Intel, Gracell, RayzeBio
Milestone falls after FDA refuses to review marketing application for nasal spray
Brief: Milestone Pharmaceuticals Receives Refusal To File Letter From U.S. FDA For New Drug Application For Etripamil
Brief: Milestone Pharmaceuticals Q3 basic EPS USD -0.35
Brief: Alta Fundamental Advisers Llc Reports 5.0% Stake In Milestone Pharmaceuticals Inc. As Of November 6- SEC Filing
Brief: Milestone Pharmaceuticals Announce Submission of New Drug Application To U.S. FDA For Etripamil
Brief: Milestone Pharmaceuticals Submits New Drug Application to the U.S. FDA for Etripamil
Health Rounds: Clues to heart risk from COVID uncovered
Brief: Milestone Pharmaceuticals Announces Etripamil Afib-Rvr Study Is Selected For Featured Science Presentation At The American Heart Association Scientific Sessions 2023